The company specializes in organ-specific therapy-delivery technology for a range of clinical applications, with a primary focus on ST-Elevation Myocardial Infarction (STEMI) heart attacks. Their innovative approach aims to significantly minimize heart muscle death and redefine the standard of care. Nirva Medical is poised to make a significant impact in the medical device industry by introducing a novel treatment that has the potential to save lives and improve patient outcomes.